Loading…
Sichuan Hebang Biotechnology expects first-half 2026 net profit attributable to shareholders of 370 million to 430 million yuan, up roughly 615% to 731% from 51.77 million yuan a year earlier. The company attributes the jump to stronger methionine and glyphosate markets and higher core operating profitability.
Higher profits at a major Chinese producer signal firmer methionine pricing, which lifts feed amino acid costs for poultry and swine formulators. Tighter methionine supply supports prices for competing amino acid and protein feed ingredients.
agrospectrumasia.comJul 24, 2026Not enough comparable past events yet for a historical read.
Moves of each commodity's benchmark from the last close before the event. Historical reads pool past events of the same kind; they describe what happened, not what will. Not investment advice.
